The Institute of Infectious Disease and Molecular Medicine (IIDMM) underwent a three-day review process by both the International Scientific Advisory Committee (ISAC) and the University Review Committee, from 2 to 4 November.
The review processes were conducted simultaneously to assess the work done over the past five years by members of the institute and the institute as a whole, and to give feedback regarding their successes and possible areas for improvement.
"The reviewers will listen to the research and provide advice to the institute at a strategic level," explains ISAC chairperson Professor Valarie Mizrahi.
The review process, which the IIDMM will undergo every five years, is used to determine the nature of the institute's future direction and funding.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Please view the republishing articles page for more information.